Apyx medical corporation to release third quarter of fiscal year 2024 financial results on november 8, 2024

Clearwater, fla., oct. 25, 2024 (globe newswire) -- apyx® medical corporation (nasdaq:apyx) (“apyx medical;” the “company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as renuvion®, today announced that financial results for the third quarter of fiscal year 2024 will be released before the market opens on friday, november 8th.
APYX Ratings Summary
APYX Quant Ranking